<DOC>
	<DOCNO>NCT00388609</DOCNO>
	<brief_summary>The purpose study learn BMS-646256 cause weight loss men woman : - overweight high blood pressure high cholesterol - obese The safety treatment also study</brief_summary>
	<brief_title>Multiple-dose Study Evaluate Efficacy , Safety Pharmacokinetics BMS-646256 Obese Subjects</brief_title>
	<detailed_description />
	<criteria>Men woman , age ≥18 ≤70 year old Body Mass Index ( BMI ) ≥30 ≤45 kg/m² OR BMI &gt; 27 &lt; 30 kg/m² hypertension and/or dyslipidemia define : Hypertension define treatment antihypertensive agent mean systolic blood pressure ≥140 ≤160 mmHg and/or diastolic blood pressure ≥ 90 ≤ 105 mmHg Dyslipidemia define stable dose treatment statin , fibrate ezetimibe ≥ 6 week and/or triglyceride ≥ 150 ≤ 600 mg/dL , LDL ≥ 130 ≤ 300 mg/dL , HDL &lt; 40 mg/dL Type 1 2 diabetes mellitus history MI prior 6 month history heart failure history symptomatic arrhythmia active hepatic disease document muscle disease history neurological symptom disease ( include limit tremor , ataxia , dizziness , neuropathy , episodes confusion , history seizure , stroke TIA ) know history major psychiatric condition ( e.g . schizophrenia anxiety disorder , dementia bipolar disorder define DSM IV criterion ) history depression suicide attempt ideation previous history surgical procedure weight loss ( e.g. , stomach stapling , bypass ) uncontrolled blood pressure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2009</verification_date>
</DOC>